Abingdon Health (LON:ABDX) Stock Price Up 2.1% – Should You Buy?

Abingdon Health Plc (LON:ABDX) shares were up 2.1% during mid-day trading on Tuesday . The stock traded as high as GBX 12.50 and last traded at GBX 12.25. Approximately 362,867 shares traded hands during mid-day trading, an increase of 14% from the average daily volume of 317,975 shares. The stock had previously closed at GBX 12.

Abingdon Health Trading Up 2.1%

The company has a 50-day simple moving average of GBX 9.92 and a 200-day simple moving average of GBX 7.83. The company has a debt-to-equity ratio of 15.05, a quick ratio of 1.96 and a current ratio of 1.91. The stock has a market cap of £30.76 million, a P/E ratio of -15.12 and a beta of 0.12.

Abingdon Health (LON:ABDX) last issued its quarterly earnings data on Tuesday, March 17th. The company reported GBX (0.43) earnings per share (EPS) for the quarter. Abingdon Health had a negative net margin of 33.88% and a negative return on equity of 55.91%.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.